Health-related quality of life after chemotherapy with or without rituximab in primary central nervous system lymphoma patients: results from a randomised phase III study

Meulen, M. van der; Bakunina, K.; Nijland, M.; Minnema, Monique C.; Cull, G.; Stevens, W.B.C.; Bromberg, Jacoline E.C.; Dirven, L.

Fulltext:

223367.pdf

Embargo:

until further notice

Size:

242.6Kb

Format:

PDF

Description:

Publisher’s version

Publication year

2020

Author(s)

Bromberg, Jacoline E.C.

Dirven, L.

Source

Annals of Oncology, 31, 8, (2020), pp. 1046-1055

ISSN

0923-7534

DOI

https://doi.org/10.1016/j.annonc.2020.04.014

Publication type

Article / Letter to editor

Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/223367

Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.

Radboud Repository

Radboud Repository

Health-related quality of life after chemotherapy with or without rituximab in primary central nervous system lymphoma patients: results from a randomised phase III study

Publication year

Author(s)

Source

ISSN

DOI

Publication type

Organization

Journal title

Volume

Issue

Page start

Page end

Subject

This item appears in the following Collection(s)